Skip to main content

Table 1 Hierarchical theoretical model of potential proactive action of the omeprazole family compounds against influenza viruses

From: Do the omeprazole family compounds exert a protective effect against influenza-like illness?

First Level
Demographic characteristics Lifestyle habits Underlying Pathologies
Aged 65 + Smoking Cardiovascular diseases
  Drinking Hypertension
  Respiratory diseases
Diabetes
Cancer
Kidney diseases
Dyslipidaemia
Gastric ulcer
  Gastric diseases
Second Level
Drugs taken
Fibrates
Statins
Antibiotics
Omeprazole Family Compounds (OFC)
Third Level
Vaccination status
Influenza vaccination
Outcome
Influenza-Like Illness (ILI)